<DOC>
	<DOCNO>NCT00458263</DOCNO>
	<brief_summary>One arm , open , prospective , intervention study assess biochemical marker growth response Growth Hormone treatment 20 Children , age 3-9 year old , idiopathic short stature . All participant treat Growth Hormone first year study ( accordance local ethic requirement , supply drug approve indication use study , additional 3 year ) follow next 3 year . The impact Growth Hormone therapy clinical laboratory parameter indicative growth response assess collect blood urine sample 4 year study period . The primary endpoint measurement height growth velocity year Growth Hormone treatment , height begin puberty final height . Secondary endpoint psychological parameter , assess questionnaire .</brief_summary>
	<brief_title>Biochemical Markers Growth Response Growth Hormone Treatment Children With Idiopathic Short Stature</brief_title>
	<detailed_description>One arm , open prospective intervention study assess biochemical marker growth response Growth Hormone treatment 20 child , age 3-9 year old , idiopathic short stature . Objectives : 1 . To determine axiological biochemical marker growth response 2 . To assess period time necessary determine parameter differentiate responder non-responders Inclusion criterion : 1 . Ages 3 &lt; 9 year 2 . Short stature height &gt; 2.25 Standard Deviation mean 3 . Prepubertal ( Tanner stage I ) commencement trial 4 . Peak Growth Hormone 10ng/ml least one provocative test Growth Hormone secretion 5 . Signing Informed consent form Exclusion criterion : 1 . Intra Uterine Growth Retardation 2 . Growth retardation associate malignancy , severe chronic disease , genetic syndrome endocrine disorder 3 . Diabetes 4 . Treatment medical product may interfere Growth Hormone effect Methods : 1 . All participant treat Growth Hormone first year study ( accordance local ethic requirement , supply drug approve indication use study , additional 3 year ) follow next 3 year . 2 . The impact Growth Hormone therapy clinical laboratory parameter indicative growth response assess collect blood urine sample 4 year study period.Samples test biochemical marker bone formation resorption 3 . The primary endpoint measurement height growth velocity year Growth Hormone treatment , height begin puberty final height . Secondary endpoint psychological parameter , assess questionnaire .</detailed_description>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Ages 3 &lt; 9 year Short stature height &gt; 2.25 Standard Deviation mean Prepubertal ( Tanner stage I ) commencement trial Peak Growth Hormone 10ng/ml least one provocative test Growth Hormone secretion Signing inform consent form Intra Uterine Growth Retardation Growth retardation associate malignancy , severe chronic disease , genetic syndrome endocrine disorder Diabetes Treatment medical product may interfere Growth Hormone</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Growth Hormone treatment</keyword>
	<keyword>ISS</keyword>
	<keyword>Biochemical marker</keyword>
	<keyword>Growth response</keyword>
</DOC>